Cell line engineering for imporved fertility treatment

Funder	European Commission
Recipient Organization	Kyron.Bio
Country	France
Start Date	Jul 01, 2023
End Date	Jan 31, 2024
Duration	214 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`101114052`

Grant Description

kyron.bio is a female led biotech company on a mission is to unclog bottlenecks in therapeutic protein production, allowing better drugs to reach patients.

We are using synthetic biology to engineer mammalian cell lines for improved bioproduction, harnessing highly efficient enzymes from diverse life forms.

Our preliminary data demonstrates a 3X yield gain for the amount of therapeutic produced in our system, with further gains in yield, activity and stability predicted post optimisation